Suchergebnisse - "O'Day, Steven J"

PubPharm (37)

1

Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy

enthalten in: Clinical chemistry | 2020

von Lin, S. | Chang, S. | Lam, S. | +11

2

Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States : An Expanded Access Program

enthalten in: Journal of immunotherapy (Hagerstown, Md. : 1997) | 2017

von Gangadhar, T. | Hwu, W. | Postow, M. | +14

3

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002) : a randomised, controlled, phase 2 trial

enthalten in: The Lancet. Oncology | 2015

von Ribas, A. | Puzanov, I. | Dummer, R. | +33

CommentIn: Lancet Oncol. 2015 Aug;16(8):873-4. - PMID 26115798

4

Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2015

von Carvajal, R. | Lawrence, D. | Weber, J. | +17

5

Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2014

von Falchook, G. | Long, G. | Kurzrock, R. | +15

6

Clinical Cancer Advances 2013 : Annual Report on Progress Against Cancer from the American Society of Clinical Oncology

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2014

von Patel, J. | Krilov, L. | Adams, S. | +16

7

Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2013

von Hodi, F. | Corless, C. | Giobbie-Hurder, A. | +21

CommentIn: J Clin Oncol. 2013 Sep 10;31(26):3173-5. - PMID 23940226

8

Final results of phase III SYMMETRY study : randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2013

von O'Day, S. | Eggermont, A. | Chiarion-Sileni, V. | +16

9

Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma

enthalten in: Investigational new drugs | 2012

von O'Day, S. | Pavlick, A. | Albertini, M. | +7

10

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours : a phase 1 dose-escalation trial

enthalten in: Lancet (London, England) | 2012

von Falchook, G. | Long, G. | Kurzrock, R. | +14

CommentIn: Lancet. 2012 May 19;379(9829):1858-9. - PMID 22608322